Selank is a tuftsin-derived heptapeptide studied for anxiolytic-like, cognitive, immune, and gene-expression effects.
Pre-loaded with a typical Selank vial. Change any value to match what you actually have.
What published research and laboratory protocols actually document for Selank. Where a compound has no single microgram figure, we say so rather than inventing one.
| Reported amount | Frequency | Route | Where this figure comes from |
|---|---|---|---|
| 900 mcg – 2.7 mg | daily in study protocols | intranasal | Clinical intranasal Selank literature commonly discusses sub-milligram to milligram daily exposure Study-context reference only; formulation and regional product context matter. |
| 100 mcg – 300 mcg | daily course in animal protocols | intraperitoneal or intranasal in animal studies | Rat behavioral research with Selank Values are commonly expressed per kg in animal work; not convertible to human guidance. |
People searching this page also look for: selank peptide dosage, selank peptide dosage chart, selank peptide injection dosage, selank peptide injection dosage chart, semax and selank peptide dosage, selank semax peptide dosage, dosage for selank peptide, selank peptide nasal spray dosage.
Selank is a synthetic heptapeptide derived from the immunomodulatory tetrapeptide tuftsin, extended with a Pro-Gly-Pro sequence. Research has examined anxiolytic-like behavior, cognitive endpoints, cytokine signaling, monoamine systems, and gene-expression changes related to GABAergic neurotransmission. Much of the literature comes from Russian research groups and includes both clinical and preclinical designs.
Education content should keep Selank in research-use framing. It is not an FDA-approved drug product, and research-grade Selank is Research Use Only and not for human consumption. Reported ranges below reflect published human or animal study contexts where available and should not be treated as a protocol.
Selank is studied as a tuftsin analog with neuroimmune and neuromodulatory effects. Published work links it to GABAergic gene-expression changes, monoamine metabolism, cytokine modulation, and anxiolytic-like behavioral outcomes. Unlike a single-receptor sedative model, Selank appears in the literature as a multi-pathway peptide with immune and CNS dimensions. That makes endpoint selection and comparator choice important in research design.
anxiety-model behavior · GABAergic signaling · neuroimmune modulation · cognitive research · cytokine response
Selank is studied by neuropharmacologists, behavioral neuroscience groups, psychopharmacology researchers, and immunology-focused peptide labs. Translational reviewers pay close attention to country of origin, formulation, route, and trial design.
Lyophilized Selank is commonly stored cold, dry, and protected from light; reconstituted research solutions are generally refrigerated and handled aseptically.
Selank is often discussed with Semax, nootropic compounds, or anxiolytic comparators, but combined CNS protocols can obscure whether changes reflect peptide effects, stress adaptation, or comparator pharmacology. Research designs should define behavioral endpoints and avoid converting regional clinical literature into general dosing advice.
The questions people actually search for, answered plainly.
Published Selank discussions include intranasal human study contexts and animal mcg/kg work. These are reference values only, not recommendations.
Small research vials are often modeled with 1-2 mL reconstitution volumes. The chosen volume sets concentration for lab calculations.
Daily exposure in the literature depends on route, formulation, and study design. Research-grade Selank is not for human consumption.
A responsible chart should separate human intranasal study references from animal per-kg experiments and clearly label all values as research context.
Behavioral and subjective endpoints in studies are usually assessed over days to weeks, while molecular endpoints can be measured on shorter timelines.
A practical human half-life is not well standardized in the mainstream literature. Effects may be discussed separately from simple plasma persistence.
It can be studied with comparators such as anxiolytic drugs or other peptides, but stacking complicates attribution and is not a use recommendation.
Primary literature on Selank. Open access where available.
Every citation above was programmatically checked against the NCBI PubMed database. Titles shown are the official indexed titles, not paraphrases.
Our support assistant walks through reconstitution, syringe units, storage, and how to read a Certificate of Analysis. Free, no account.
Read the guides